期刊文献+

降钙素原在重型颅脑损伤患者医院感染早期诊断中的应用 被引量:7

The application of serum procalcition in early diagnosis of nosocomial infection in severe cerebral injury
原文传递
导出
摘要 目的探讨降钙素原(PCT)在重型颅脑损伤患者医院感染早期诊断中的临床应用价值。方法纳入因重型颅脑损伤人住ICU患者58例,在入住ICU时及入住第3天时检测PCT、C反应蛋白水平及白细胞计数,监测医院感染发生情况。结果两组入住ICU时血清PCT水平差异无统计学意义(P〉0.05),入住ICU第3天时感染组血清PCT水平明显升高,与非感染组差异有统计学意义(t=5.44,P〈0.01);两组问C反应蛋白、白细胞计数在人住ICU时及人住ICU第3天时差异均无统计学意义(均P〉0.05)。结论降钙素原测定有助于早期诊断急性颅脑疾病患者医院感染,早期合理选用抗生素,减少细菌耐药性的发生,可降低病死率。 Objective To investigate clinical value of serum procalcition(PCT) in early diagnosis of nosocomial infection in severe cerebral injury. Methods 58 patients with severe cerebral injury needing ICU monitoring were enrolled. Levels of serum PCT and C-reactive protein(CRP) and white blood cell(WBC) and nosocomial infection when entering ICU or on days 3 were observed. Results There were not difference in level Serum PCT when entering ICU in infection group compared with non-infection group(P 〉 0.05). Serum PCT increeassd remarkably when entering ICU on days 3 in infection group as compared with non-infection group, the difference was significant (t = 5.44 ,P 〈 0. 01 ). There were not difference in CRP and WBC level when entering ICU or on days 3 ( all P 〉 0.05 ). Conclusion Detection of serum PCT helps diagnosis early nosocomial infection in patients with severe cerebral injury. It is suggested that antibiotics should be chosen early in patients with obviously increased PCT, control abuse of an- tibiotics contributes to reduce incidence of drug resistance and mortality.
出处 《中国基层医药》 CAS 2013年第2期237-239,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 降钙素原 医院感染 C反应蛋白 白细胞 Procalcition In-hospital infectionl C-reactive protein White blood cell
  • 相关文献

参考文献7

二级参考文献101

共引文献291

同被引文献75

  • 1邓佳,陈红,唐永江,梁斌苗,冯玉麟.降钙素原指导ICU重症感染抗生素应用的Meta分析[J].中国呼吸与危重监护杂志,2011,10(2):176-180. 被引量:46
  • 2时兢,缪昉,荣菊芬,沈波,穆会君.血清降钙素原检测对院内深部真菌感染诊断价值的探讨[J].内科急危重症杂志,2004,10(4):203-204. 被引量:23
  • 3Ahn S, Kim WY, Kim SH, et al. Role of procalciton and C-reac- tive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral peneumonia. Infl Other Respir Vir,2011,5(6) : 398-403.
  • 4Jereb M, Kotar T. Usefulness of procaocitonin to differentiate typi- cal from atypical community-acqured pneumonia. Wien Klin Wochenschr,2006,118 ( 5-6 ) : 170-174.
  • 5Kruger S, Ewig S, Papassotiriou J, et al. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German compe- tence network CAPNETZ. Respir Res,2009,10:65.
  • 6Naderi M, Hashemi M, Kouhpayeh H, et al. The status of serum procalcitonnin in pulmonary disease. J Pak Med Assoc, 2009,59 (9) :647-648.
  • 7Ugajin M,Miwa S,Shirai M,et al. Usefulless of serum procalcito- nin levels in pulmonary tuberculosis. Eur Respir J,2011,37 ( 2 ) : 371-375.
  • 8Dombusch H J, Stronger V, Kerbl R, et al. Procalcitonin-a marker of invasive fungal infection. Support Care Cancer,2005,13 ( 5 ) : 343-346.
  • 9Crouzet J, Fancher JF, Toubin M, et al. Serum C-reactive protein (CRP) and procalcitonin (PCT)levels and kinetics in patients with leptospirosis. Eur J Clin Microbiol Infect Dis,2011,30 (2) : 299-302.
  • 10van Nieuwkoop C, Bonten TN, Van't Wout JW, et al. Procalcito- nin reflects bacteremia and bacterial load in urosepsis syndrome : a prospective observational study. Cfit Care,2010,14 (6) : R206.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部